Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News

Sunscreen, Collagen: Do Viral Social Media Claims Hold Up?

Viral discussions about sun protection, vitamin D, and oral collagen often outpace the evidence, leaving clinicians to weigh the benefits, limitations, and patient concerns.

AI-Tomography Detects Subclinical Basal Cell Skin Cancers

AI-assisted coherence tomography shows feasibility as a method of detecting basal cell carcinomas when they are still undetectable, but clinical relevance is still being evaluated.

GLP1R Expression Tied to Male Pattern Hair Loss

A genetic analysis suggests that increased GLP1R expression is linked to higher risk for male pattern hair loss.

Social Media Tied to Heavier Chemical Product Use in Teens

Teens who follow beauty influencers and watch skincare tutorials use far more personal care products, raising concerns over chemical exposure.

Young Adult Cancer Survival Rates Accelerate

Researchers have analyzed annual survival data between AYA patients aged 15-39 years and patients in younger and older age groups between 1975 and 2017.

HS Severely Impairs Quality of Life, Even in Mild Disease

Quality of life is severely impaired in patients with hidradenitis suppurativa, including those traditionally classified as having mild disease.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Todays Updates

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Latest News

Viral discussions about sun protection, vitamin D, and oral collagen often outpace the evidence, leaving clinicians to weigh the benefits, limitations, and patient concerns.

AI-assisted coherence tomography shows feasibility as a method of detecting basal cell carcinomas when they are still undetectable, but clinical relevance is still being evaluated.

A genetic analysis suggests that increased GLP1R expression is linked to higher risk for male pattern hair loss.

Teens who follow beauty influencers and watch skincare tutorials use far more personal care products, raising concerns over chemical exposure.

Researchers have analyzed annual survival data between AYA patients aged 15-39 years and patients in younger and older age groups between 1975 and 2017.

Quality of life is severely impaired in patients with hidradenitis suppurativa, including those traditionally classified as having mild disease.

News All Time

Does Tapering TNF Inhibitors Maintain Low Disease Activity?

In patients with psoriatic arthritis and axial spondyloarthritis, a treat-to-target tapering strategy for TNF inhibitors may maintain low disease activity for up to 2 years.

FDA Approves First Oral Drug for Dermatomyositis in Adults

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune disease, in adults.

How Safe Is Lifileucel After Patients Go Home?

The T-cell therapy’s inpatient toxicity is well-characterized, but the risks patients may face after hospital discharge have been unclear.

Early Step-Down Safe, Cost-Effective in Stable Candidiasis

Switching from an echinocandin to an azole within 5 days is not associated with worse outcomes in clinically stable adults with invasive candidiasis, a study shows.

China Approves J&J Psoriasis Pill Icotyde, Says Drugmaker

China's drug regulator has approved Johnson & Johnson's oral pill ⁠for psoriasis, the company said on Thursday, intensifying competition in the ⁠world's second-largest...

Vulvar Lichen Sclerosus Affects 1 in 700 US Women

Vulvar lichen sclerosus shows markedly higher rates in women over 60, with White women experiencing the highest burden, a study shows.

Brepocitinib Controls Skin Disease in Dermatomyositis

Brepocitinib produces rapid and sustained improvements in skin disease, itch, and skin-related quality of life in adults with dermatomyositis.

Biologic Choice May Affect PsA Progression in Psoriasis

In patients with psoriasis, interleukin-targeting inhibitors are associated with a lower risk for psoriatic arthritis than TNF inhibitors, a long-term real-world study finds.

ctDNA Detects Postsurgical Merkel Cell Recurrence

Circulating tumor DNA surveillance detects Merkel cell carcinoma recurrence after curative-intent surgery.

Data Gaps Hinder Response to Climate-Driven Infections

Climate change is reshaping infectious disease risk in Italy and beyond, highlighting the need for better diagnostics, integrated data, and stronger global cooperation.

Ruxolitinib Improves Vitiligo Outcomes in Real-World Study

Topical ruxolitinib shows sustained repigmentation through 52 weeks with improvements in anxiety and depression in patients with non-segmental vitiligo.

Longer Targeted Therapy May Not Raise Cancer Risk in SpA

Using targeted therapy for spondyloarthritis for more than 6 months per year is not associated with an increased risk for cancer compared with using targeted therapy for shorter durations.

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

Clinical Crosstalk: Integrating ICIs and Strengthening Collaborative Care in NMSC

In 20 Different Cancers, Men More Likely to Be Diagnosed at a Later Stage

More late-stage diagnoses add to higher cancer mortality burden for men

Guidelines Help Spot Dermatomyositis Patients at High Risk for Cancer

IMACS guidelines are clinically useful for identifying high-risk populations, researchers say

Viral NeeDoh Trend Leading to Scalding Injuries, Doctors Warn

Kids are microwaving the squishy toy, making the gel inside hot enough to boil and explode

Recommended News For You

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

An ultrasound breast patch with conformability might help with early breast cancer detection.

Improved end-of-life conversations for cancer patients are identified by a new study.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

There has been a new target found that might stop blood cancer.

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

Recommended Articles For You

Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA 

Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction  

Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies 

Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Sickle Cell Gene Therapy for Young Kids

2.

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

3.

Combo Therapy Boosts Early CML Response but Not Long Term

4.

Increased Exercise May Lower the Risk of Prostate Cancer.

5.

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

1.

Epigenetic Signatures for Multi-Cancer Screening

2.

Liquid Biopsy in Cancer Screening: An Evidence-Based Review for Clinicians

3.

Integrated Perspectives in Oncology in Clinical Decision-Making

4.

Immune Niches Supporting Tumor Resistance: Mechanisms, Clinical Implications, and Emerging Therapies

5.

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

When Unexplained Bruising May Require Blood Testing

2.

Managing Common Side Effects During Cancer Treatment

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot